Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IFNAR1 | P17181 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | NPY1R | P25929 | 1/20 | 0.42 |
| ▸ | NPY2R | P49146 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8038665 | 0.83 | IFNAR1 (0.41) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL8044798 | 0.80 | IFNAR1 (0.39) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL1057367 | 0.78 | IFNAR1 (0.47) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL17058596 | 0.78 | IFNAR1 (0.43) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL6293960 | 0.78 | IFNAR1 (0.43) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL2399229 | 0.78 | HDAC3 (0.45) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL2232580 | 0.78 | HDAC3 (0.45) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL2607720 | 0.78 | L3MBTL1 (0.50) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL2117027 | 0.78 | IFNAR1 (0.44) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL5071846 | 0.77 | IFNAR1 (0.37) | IFNAR1ALDH1A1LMNAMAPK1NPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220119567-A1 | NETWORK POLYMERS AND METHODS OF MAKING AND USING SAME | NATIONAL SCIENCE FOUNDATION | 2022-04-21 | — | — | US | claimed |
| WO-2021012700-A1 | COMPOUND FOR ENCAPSULATION FILM AND COMPOSITION THEREOF, AND FILM, ORGANIC LIGHT-EMITTING DEVICE AND ENCAPSULATION METHOD | 吉林奥来德光电材料股份有限公司 | 2021-01-28 | — | — | WO | claimed |
| CN-106366324-B | Hyperbranched polymer coated nano-particle, preparation method thereof, brightness enhancement composition containing hyperbranched polymer coated nano-particle, brightness enhancement film and LED display | 张家港康得新光电材料有限公司 | 2020-03-03 | — | — | CN | claimed |
| US-20110043727-A1 | ADHESIVE LAYER FOR MULTILAYER OPTICAL FILM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-02-24 | — | — | US | claimed |
| EP-2263112-A2 | ADHESIVE LAYER FOR MULTILAYER OPTICAL FILM | 3M Innovative Properties Company (US) | 2010-12-22 | — | — | EP | claimed |
| WO-2009145939-A1 | ADHESIVE LAYER FOR MULTILAYER OPTICAL FILM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-12-03 | — | — | WO | claimed |
| WO-2009145998-A2 | ADHESIVE LAYER FOR MULTILAYER OPTICAL FILM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-12-03 | — | — | WO | claimed |
| US-20070082988-A1 | Compositions for articles comprising replicated microstructures | GENERAL ELECTRIC COMPANY (US) | 2007-04-12 | — | — | US | claimed |
| US-7192983-B2 | Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors | G.D. SEARLE & CO. (US) | 2007-03-20 | — | — | US | claimed |
| US-20060128853-A1 | Compositions for articles comprising replicated microstructures | GENERAL ELECTRIC COMPANY (US) | 2006-06-15 | — | — | US | claimed |
| US-20060074247-A1 | N-protected/N-substituted-beta-amino hydroxy sulfonates | G.D. SEARLE & CO. (US) | 2006-04-06 | — | — | US | claimed |
| US-6586627-B1 | Blocking carbocyclic oxo, amines such as 2-(bis(phenylmethyl) amino)-3-phenylpropanal to form 2-(Bis(phenylmethyl)amino)-1-hydroxy-3-phenylpropylsulfonic Acid Salts, having storage stability; chemical intermediates for enzyme inhibitors | G. D. SEARLE & CO. | 2003-07-01 | — | — | US | claimed |
| WO-2000079312-A1 | HIGH REFRACTIVE INDEX COMPOSITIONS FOR OPHTHALMIC IMPLANTS | BAUSCH & LOMB SURGICAL, INC. (US) | 2000-12-28 | — | — | WO | claimed |
| US-6147253-A | STABILIZED FORM OF N-PROTECTED/N-SUBSTITUTED ALPHA-AMINO ALDEHYDES | G. D. SEARLE & CO. (US) | 2000-11-14 | — | — | US | claimed |
| EP-0861233-B1 | N-PROTECTED/N-SUBSTITUTED-BETA-AMINO HYDROXY SULFONATES | SEARLE & CO (US) | 2000-05-03 | — | — | EP | claimed |
| US-5939587-A | DEBLOCKING, DESALTING, DESULFONATING AND OXIDATING TO ALDEHYDE; STORAGE STABILITY, MATERIALS HANDLING | G. D. SEARLE & COMPANY (US) | 1999-08-17 | — | — | US | claimed |
| US-5847201-A | N-protected/N-substituted-beta-amino hydroxy sulfonates | G.D. SEARLE & CO. (US) | 1998-12-08 | — | — | US | claimed |
| EP-0861233-A1 | N-PROTECTED/N-SUBSTITUTED-BETA-AMINO HYDROXY SULFONATES | G.D. SEARLE & CO. (US) | 1998-09-02 | — | — | EP | claimed |
| EP-0804428-A1 | BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1997-11-05 | — | — | EP | claimed |
| WO-1997018190-A1 | N-PROTECTED/N-SUBSTITUTED-BETA-AMINO HYDROXY SULFONATES | G.D. SEARLE & CO. (US) | 1997-05-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074247-A1 | N-protected/N-substituted-beta-amino hydroxy sulfonates | AANAT, AASDHPPT, ALDH7A1 | IFNAR1 1570/4885ALDH1A1 30/4885LMNA 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.